Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma

Recent advances in the genomic study have revolutionized the discovery of molecular biomarkers in glioma not only to aid in targeted therapy but also to prognosticate character of tumor and outcome of a patient. The usually benign nature of pilocytic astrocytoma (PA) can now be challenged with the d...

Full description

Saved in:
Bibliographic Details
Published in:Child's nervous system 2021-03, Vol.37 (3), p.1003-1008
Main Authors: Francis, Jacintha Vikeneswary, Tanrıkulu, Bahattin, Danyeli, Ayca Ersen, Özek, M. Memet
Format: Article
Language:English
Subjects:
Case Report
Medicine
Medicine & Public Health
Neurosciences
Neurosurgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c298t-e0db9b5d127a21e2c37a288d8cc740f8eb30c5620cc15d1a348d2e55780419793
container_end_page 1008
container_issue 3
container_start_page 1003
container_title Child's nervous system
container_volume 37
creator Francis, Jacintha Vikeneswary
Tanrıkulu, Bahattin
Danyeli, Ayca Ersen
Özek, M. Memet
description Recent advances in the genomic study have revolutionized the discovery of molecular biomarkers in glioma not only to aid in targeted therapy but also to prognosticate character of tumor and outcome of a patient. The usually benign nature of pilocytic astrocytoma (PA) can now be challenged with the discovery of genomic alterations that could promote more aggressive clinical behavior. CDKN2A deletion and ATRX gene inactivation or mutation have been the most common molecular alterations in worse prognosis. We will discuss a case of pilocytic astrocytoma showing the progressive recurrence with pilomyxoid features and the presence of TERT promoter mutation.
doi_str_mv 10.1007/s00381-020-04803-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2435529773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2435529773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-e0db9b5d127a21e2c37a288d8cc740f8eb30c5620cc15d1a348d2e55780419793</originalsourceid><addsrcrecordid>eNp9kM9KAzEQh4MotlZfwIPk6GV1kmy62ZNIqVooCFLPIZtNS8r-qUlW6a0Poi_XJzG11aMQmIF882PmQ-iSwA0ByG49ABMkAQoJpAJYwo5Qn6SMJcA4HKM-UD5MMkihh868XwIQLmh-inqMCsKAp31UTDy2ASvcmA-su2rlbLjD283nbPwywyvX1m0wDtddUMG2zXbzhW2DVXyLhTPe23eDV6a0Kjir8cpWrV6H2Ckf3K5ta3WOTuaq8ubiUAfo9WE8Gz0l0-fHyeh-mmiai5AYKIu84CWhmaLEUM1iFaIUWmcpzIUpGGg-pKA1iZRiqSip4TwTkJI8y9kAXe9z49ZvnfFB1tZrU1WqMW3nJU0Z5zTPMhZRuke1a713Zi7j3bVya0lA7tzKvVsZ3coft3I3dHXI74ralH8jvzIjwPaAj1_Nwji5bDvXxJv_i_0GlE2GSg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435529773</pqid></control><display><type>article</type><title>Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma</title><source>Springer Nature</source><creator>Francis, Jacintha Vikeneswary ; Tanrıkulu, Bahattin ; Danyeli, Ayca Ersen ; Özek, M. Memet</creator><creatorcontrib>Francis, Jacintha Vikeneswary ; Tanrıkulu, Bahattin ; Danyeli, Ayca Ersen ; Özek, M. Memet</creatorcontrib><description>Recent advances in the genomic study have revolutionized the discovery of molecular biomarkers in glioma not only to aid in targeted therapy but also to prognosticate character of tumor and outcome of a patient. The usually benign nature of pilocytic astrocytoma (PA) can now be challenged with the discovery of genomic alterations that could promote more aggressive clinical behavior. CDKN2A deletion and ATRX gene inactivation or mutation have been the most common molecular alterations in worse prognosis. We will discuss a case of pilocytic astrocytoma showing the progressive recurrence with pilomyxoid features and the presence of TERT promoter mutation.</description><identifier>ISSN: 0256-7040</identifier><identifier>EISSN: 1433-0350</identifier><identifier>DOI: 10.1007/s00381-020-04803-3</identifier><identifier>PMID: 32813054</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Case Report ; Medicine ; Medicine &amp; Public Health ; Neurosciences ; Neurosurgery</subject><ispartof>Child's nervous system, 2021-03, Vol.37 (3), p.1003-1008</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-e0db9b5d127a21e2c37a288d8cc740f8eb30c5620cc15d1a348d2e55780419793</cites><orcidid>0000-0002-9096-8685</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32813054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Francis, Jacintha Vikeneswary</creatorcontrib><creatorcontrib>Tanrıkulu, Bahattin</creatorcontrib><creatorcontrib>Danyeli, Ayca Ersen</creatorcontrib><creatorcontrib>Özek, M. Memet</creatorcontrib><title>Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma</title><title>Child's nervous system</title><addtitle>Childs Nerv Syst</addtitle><addtitle>Childs Nerv Syst</addtitle><description>Recent advances in the genomic study have revolutionized the discovery of molecular biomarkers in glioma not only to aid in targeted therapy but also to prognosticate character of tumor and outcome of a patient. The usually benign nature of pilocytic astrocytoma (PA) can now be challenged with the discovery of genomic alterations that could promote more aggressive clinical behavior. CDKN2A deletion and ATRX gene inactivation or mutation have been the most common molecular alterations in worse prognosis. We will discuss a case of pilocytic astrocytoma showing the progressive recurrence with pilomyxoid features and the presence of TERT promoter mutation.</description><subject>Case Report</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><issn>0256-7040</issn><issn>1433-0350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM9KAzEQh4MotlZfwIPk6GV1kmy62ZNIqVooCFLPIZtNS8r-qUlW6a0Poi_XJzG11aMQmIF882PmQ-iSwA0ByG49ABMkAQoJpAJYwo5Qn6SMJcA4HKM-UD5MMkihh868XwIQLmh-inqMCsKAp31UTDy2ASvcmA-su2rlbLjD283nbPwywyvX1m0wDtddUMG2zXbzhW2DVXyLhTPe23eDV6a0Kjir8cpWrV6H2Ckf3K5ta3WOTuaq8ubiUAfo9WE8Gz0l0-fHyeh-mmiai5AYKIu84CWhmaLEUM1iFaIUWmcpzIUpGGg-pKA1iZRiqSip4TwTkJI8y9kAXe9z49ZvnfFB1tZrU1WqMW3nJU0Z5zTPMhZRuke1a713Zi7j3bVya0lA7tzKvVsZ3coft3I3dHXI74ralH8jvzIjwPaAj1_Nwji5bDvXxJv_i_0GlE2GSg</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Francis, Jacintha Vikeneswary</creator><creator>Tanrıkulu, Bahattin</creator><creator>Danyeli, Ayca Ersen</creator><creator>Özek, M. Memet</creator><general>Springer Berlin Heidelberg</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9096-8685</orcidid></search><sort><creationdate>20210301</creationdate><title>Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma</title><author>Francis, Jacintha Vikeneswary ; Tanrıkulu, Bahattin ; Danyeli, Ayca Ersen ; Özek, M. Memet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-e0db9b5d127a21e2c37a288d8cc740f8eb30c5620cc15d1a348d2e55780419793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Case Report</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Francis, Jacintha Vikeneswary</creatorcontrib><creatorcontrib>Tanrıkulu, Bahattin</creatorcontrib><creatorcontrib>Danyeli, Ayca Ersen</creatorcontrib><creatorcontrib>Özek, M. Memet</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Child's nervous system</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Francis, Jacintha Vikeneswary</au><au>Tanrıkulu, Bahattin</au><au>Danyeli, Ayca Ersen</au><au>Özek, M. Memet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma</atitle><jtitle>Child's nervous system</jtitle><stitle>Childs Nerv Syst</stitle><addtitle>Childs Nerv Syst</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>37</volume><issue>3</issue><spage>1003</spage><epage>1008</epage><pages>1003-1008</pages><issn>0256-7040</issn><eissn>1433-0350</eissn><abstract>Recent advances in the genomic study have revolutionized the discovery of molecular biomarkers in glioma not only to aid in targeted therapy but also to prognosticate character of tumor and outcome of a patient. The usually benign nature of pilocytic astrocytoma (PA) can now be challenged with the discovery of genomic alterations that could promote more aggressive clinical behavior. CDKN2A deletion and ATRX gene inactivation or mutation have been the most common molecular alterations in worse prognosis. We will discuss a case of pilocytic astrocytoma showing the progressive recurrence with pilomyxoid features and the presence of TERT promoter mutation.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32813054</pmid><doi>10.1007/s00381-020-04803-3</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9096-8685</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0256-7040
ispartof Child's nervous system, 2021-03, Vol.37 (3), p.1003-1008
issn 0256-7040
1433-0350
language eng
recordid cdi_proquest_miscellaneous_2435529773
source Springer Nature
subjects Case Report
Medicine
Medicine & Public Health
Neurosciences
Neurosurgery
title Is it a new culprit? “TERT promoter mutation” in an aggressive pediatric pilocytic astrocytoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A03%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20it%20a%20new%20culprit?%20%E2%80%9CTERT%20promoter%20mutation%E2%80%9D%20in%20an%20aggressive%20pediatric%20pilocytic%20astrocytoma&rft.jtitle=Child's%20nervous%20system&rft.au=Francis,%20Jacintha%20Vikeneswary&rft.date=2021-03-01&rft.volume=37&rft.issue=3&rft.spage=1003&rft.epage=1008&rft.pages=1003-1008&rft.issn=0256-7040&rft.eissn=1433-0350&rft_id=info:doi/10.1007/s00381-020-04803-3&rft_dat=%3Cproquest_cross%3E2435529773%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-e0db9b5d127a21e2c37a288d8cc740f8eb30c5620cc15d1a348d2e55780419793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2435529773&rft_id=info:pmid/32813054&rfr_iscdi=true